FR2587216B1 - Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie - Google Patents

Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie

Info

Publication number
FR2587216B1
FR2587216B1 FR8607946A FR8607946A FR2587216B1 FR 2587216 B1 FR2587216 B1 FR 2587216B1 FR 8607946 A FR8607946 A FR 8607946A FR 8607946 A FR8607946 A FR 8607946A FR 2587216 B1 FR2587216 B1 FR 2587216B1
Authority
FR
France
Prior art keywords
anemia
treatment
pharmaceutical composition
composition based
nasal administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8607946A
Other languages
English (en)
Other versions
FR2587216A1 (fr
Inventor
Naoto Shimoda
Kazuo Igusa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FR2587216A1 publication Critical patent/FR2587216A1/fr
Application granted granted Critical
Publication of FR2587216B1 publication Critical patent/FR2587216B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR8607946A 1985-06-04 1986-06-03 Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie Expired FR2587216B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12112685 1985-06-04

Publications (2)

Publication Number Publication Date
FR2587216A1 FR2587216A1 (fr) 1987-03-20
FR2587216B1 true FR2587216B1 (fr) 1989-09-22

Family

ID=14803522

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8607946A Expired FR2587216B1 (fr) 1985-06-04 1986-06-03 Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie

Country Status (4)

Country Link
JP (1) JPH0676336B2 (fr)
DE (1) DE3618561A1 (fr)
FR (1) FR2587216B1 (fr)
GB (1) GB2177914B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601923A1 (de) * 1986-01-23 1987-07-30 Behringwerke Ag Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
JP2858752B2 (ja) * 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
EP0459516A1 (fr) * 1990-06-01 1991-12-04 Kirin-Amgen, Inc. Formes d'administration orale de protéines biologiquement actifs
IL100874A (en) * 1991-02-08 1996-01-19 Pro Neuron Inc Oxiforin nucleosides and their composition, for use as medicines, their preparation and pharmaceutical preparations containing them
DE4126984A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, gut vertraeglichen arzneimitteln fuer infusions- oder injektionszwecke
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5354934A (en) * 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
GB9506051D0 (en) 1995-03-24 1995-05-10 Univ Singapore Gene expression
WO2004084859A2 (fr) 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Formulations nasales de calcitonine contenant du chlorobutanol
CU23317A1 (es) * 2005-07-22 2008-10-22 Ct De Investigacia N Y Desarro Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central
EP2837392A3 (fr) * 2009-09-15 2015-05-13 Kaneka Corporation Érythropoïétine modifiée à laquelle est ajoutée une molécule à chaîne longue soluble dans l'eau
JP5672554B2 (ja) * 2010-08-19 2015-02-18 Ｊｃｒファーマ株式会社 皮下又は経皮吸収用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
JPS6045849B2 (ja) * 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
AU572815B2 (en) * 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPH0686480B2 (ja) * 1983-02-21 1994-11-02 雪印乳業株式会社 エリスロポエチン製造用モノクローナル抗体
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
JPS6197229A (ja) * 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPS61126014A (ja) * 1984-11-22 1986-06-13 Teijin Ltd 経鼻投与用水性液剤
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors

Also Published As

Publication number Publication date
JPH0676336B2 (ja) 1994-09-28
GB2177914A (en) 1987-02-04
JPS6289627A (ja) 1987-04-24
GB2177914B (en) 1989-10-25
GB8613320D0 (en) 1986-07-09
DE3618561A1 (de) 1987-01-02
FR2587216A1 (fr) 1987-03-20

Similar Documents

Publication Publication Date Title
FR2576792B1 (fr) Composition pharmaceutique a base d'erythropoietine humaine pour le traitement de l'anemie de l'arthrite rhumatoide
FR2576791B1 (fr) Composition pharmaceutique a base d'erythropoietine humaine pour le traitement de l'anemie de tumeurs malignes
FR2508318B1 (fr) Bandage pour l'administration d'une substance pharmaceutique
DZ1077A1 (fr) Nouvelles préparation pharmaceutique pour administration orale.
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
IT1190466B (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
MC1782A1 (fr) Preparation pharmaceutique
BE849632A (fr) Composition pharmaceutique pour l'administration orale
FR2587216B1 (fr) Composition pharmaceutique a base d'erythropoietine humaine destinee a etre administree par voie nasale pour le traitement de l'anemie
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
FR2573426B1 (fr) Procede de preparation de silibinine depourvue d'isosilybine et medicaments renfermant de la silibinine
BE890796A (fr) Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
PT66850B (fr) Procede pour la preparation d'une composition pharmaceutique
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2574295B1 (fr) Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies
BE894272A (fr) Nouveaux medicaments a base de derives de la 1,4-dihydropyridine, pour le traitement des cephalees vasculaires
FR2585953B1 (fr) Composition pharmaceutique pour l'administration orale contenant de l'ubiquinone et procede
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
FR2515961B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
FR2623089B1 (fr) Composition pharmaceutique pour l'administration parenterale de navelbine

Legal Events

Date Code Title Description
ST Notification of lapse